SCHEMBL13021287

SCHEMBL13021287

Cc1ncnc2c1c(/C(N)=N\O)cn2[C@@H]1OC(CO)C(O)[C@H]1O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.75
▸ STAT6 P42226 2/20 0.75
▸ HIF1A Q16665 2/20 0.75
▸ ALDH1A1 P00352 2/20 0.60
▸ HTT P42858 2/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ GALR3 O60755 1/20 0.60
▸ S1PR4 O95977 1/20 0.60
▸ MAPT P10636 1/20 0.60
▸ S1PR1 P21453 1/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ PAX8 Q06710 1/20 0.60
▸ ADK P55263 10/20 0.53
▸ DOT1L Q8TEK3 2/20 0.53
▸ SLC29A1 Q99808 1/20 0.53
▸ MAPK1 P28482 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ ALOX15 P16050 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25025607 0.88 NPC1 (0.77) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL3658125 0.86 HIF1A (1.00) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL3658127 0.86 HIF1A (1.00) TP53STAT6HIF1AALDH1A1HTT
Hydrochloric Acid SCHEMBL2386489 0.85 HIF1A (0.98) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL2788446 0.83 HIF1A (0.77) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL2788440 0.83 HIF1A (0.77) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL13021233 0.82 HIF1A (0.75) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL2784937 0.82 HIF1A (0.75) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL2784929 0.82 HIF1A (0.75) TP53STAT6HIF1AALDH1A1HTT
SCHEMBL17816346 0.82 ADK (0.61) TP53STAT6HIF1AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297079-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION CHIMERIX, INC. (US) 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297079-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION HAVCR2, EIF2AK2, OAT TP53 2531/4885STAT6 1884/4885HIF1A 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback